tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Peter Lawson, 13 are a SELL (5.58%), 193 are a BUY (82.83%), 27 are a HOLD (11.59%).
Analyst Peter Lawson, currently employed at BARCLAYS, carries an average stock price target met ratio of 64.49% that have a potential upside of 45.9% achieved within 326 days. Previously, Peter Lawson worked at ROTH MKM, MIZUHO, TRUIST.
Peter Lawson’s has documented 466 price targets and ratings displayed on 56 stocks. The coverage is on Healthcare, Technology, Energy, Consumer Defensive sectors.
Most recent stock forecast was given on IOVA, Iovance Biotherapeutics at 17-Dec-2025.
Analyst best performing recommendations are on CLVS (CLOVIS ONCOLOGY).
The best stock recommendation documented was for CLVS (CLOVIS ONCOLOGY) at 9/8/2015. The price target of $103 was fulfilled within 2 days with a profit of $18.62 (22.07%) receiving and performance score of 110.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Feb-2025
$52
$15.64 (43.01%)
$50
10 days ago
(21-Jul-2026)
0/8 (0%)
$14.64 (39.19%)
Buy Since 05-Jan-2024
$41
$4.64 (12.76%)
$36
24 days ago
(07-Jul-2026)
10/11 (90.91%)
$-3.01 (-6.84%)
95
Hold Since 01-Dec-2022
$31
$-6.9 (-18.21%)
$36
1 months 20 days ago
(11-Jun-2026)
8/8 (100%)
$2.28 (7.94%)
138
Buy Since 04-Dec-2021
$40
$2.1 (5.54%)
$41
2 months 2 days ago
(29-May-2026)
8/14 (57.14%)
$10.6 (36.05%)
528
Hold Since 03-May-2024
$32
$-5.9 (-15.57%)
$25
3 months 30 days ago
(01-Apr-2026)
6/6 (100%)
$-2.19 (-6.41%)
168
What Year was the first public recommendation made by Peter Lawson?
